BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6608609)

  • 1. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
    Yamada S; Miyagawa Y; Komiyama A; Akabane T
    Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human nonspecific killer cells].
    Thränhardt H; Zintl F; Milleck J; Jantscheff P; Hermann J; Fuchs D; Voigt P; Metz O; Löbe LP; Mohr F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):390-407. PubMed ID: 6182059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer (NK) activity in children with acute lymphoblastic leukemia.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):127-33. PubMed ID: 6946050
    [No Abstract]   [Full Text] [Related]  

  • 6. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
    Suzuki M
    Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of the natural killer activity of lymphocytes from healthy donors and patients with chronic lympholeukemia through the interaction of T- and non-T cells].
    Khonina NA; Shubinskiĭ GZ; Lozovoĭ VP
    Biull Eksp Biol Med; 1987 Mar; 103(3):321-3. PubMed ID: 3493815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of natural killers in acute leukemia in children].
    Blinov MN; Vartanian NL; Luganova IS; Klubovskaia NI; Alekseev NA
    Vopr Onkol; 1988; 34(4):421-5. PubMed ID: 3376454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of natural killer and interleukin-2 activated killer cell activity in ataxia-telangiectasia with T cell deficiency.
    Tsuge I; Matsuoka H; Torii S; Okada J; Mizuno T; Matsuoka M; Kodera Y; Takahashi T
    J Clin Lab Immunol; 1987 May; 23(1):7-13. PubMed ID: 3497277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous lymphocyte-mediated cytotoxicity and antibody-dependent cell cytotoxicity of human effector cells].
    Thränhardt H; Soeberdt R; König A; Zintl F; Metz O; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):831-42. PubMed ID: 6200394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
    Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
    Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activity in childhood acute lymphoblastic leukaemia in remission.
    Dickinson AM; Proctor SJ; Jacobs E; Reid MM; Walker W; Craft AW; Kernahan J
    Br J Haematol; 1985 Jan; 59(1):45-53. PubMed ID: 3855649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cellular and humoral immunity in childhood acute lymphoblastic leukemia in long-term remission.
    Katz J; Walter BN; Bennetts GA; Cairo MS
    West J Med; 1987 Feb; 146(2):179-87. PubMed ID: 3493591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia.
    Yabuhara A; Kawai H
    Pediatr Res; 1990 Dec; 28(6):572-8. PubMed ID: 2284152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased natural killer cell activity in children with untreated acute leukemia.
    Nasrallah AG; Miale TD
    Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.